Market Research Reports and Industry Reports

GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

GeNO LLC (GeNO) is a biotechnology company that designs, develops and commercializes products for pulmonary and cardiac diseases. The company offers development of inhaled nitric oxide (NO) products for use in hospital setting and for longer-term applications. It provides next-generation drug products which include GeNOsyl Acute DS for use in the hospital setting, and GeNOsyl Chronic DS, a lightweight system that used by patients with chronic diseases. Its technologies comprise GeNO nitric oxide technology, single-use drug cassette, reactor cartridges, and consoles and controllers. GeNO is headquartered in Lexington, Massachusetts, the US.

GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9
GeNO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GeNO LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
GeNO Raises US$14.7 Million In Venture Financing 11
Equity Offering 12
GeNO Withdraws IPO for USD50 Million 12
Acquisition 13
The Medicines Company Acquires Minority Stake In GeNO 13
GeNO LLC - Key Competitors 14
GeNO LLC - Key Employees 15
GeNO LLC - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables


GeNO LLC, Pharmaceuticals & Healthcare, Key Facts 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9
GeNO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GeNO Raises US$14.7 Million In Venture Financing 11
GeNO Withdraws IPO for USD50 Million 12
The Medicines Company Acquires Minority Stake In GeNO 13
GeNO LLC, Key Competitors 14
GeNO LLC, Key Employees 15
GeNO LLC, Other Locations 16

List Of Figures


GeNO LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9

Global Isoeugenol Benzyl Ether (CAS: 120-11-6) Sales Market Report 2017

In this report, the global Isoeugenol Benzyl Ether (CAS: 120-11-6) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end

USD 4000View Report

Global Genomics Market Size, Status and Forecast 2022

This report studies the global Genomics market, analyzes and researches the Genomics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on

USD 3300View Report

Z-Medica LLC - Medical Equipment - Deals and Alliances Profile

Z-Medica LLC (Z- Medica) is a medical device company that develops and manufactures hemostatic medical devices. The companys products include sterile nonwoven gauzes, haemostatic sponges impregnated with kaolin, haemostatic bandages

USD 250View Report

Insituform Technologies LLC - Oil & Gas - Deals and Alliances Profile

Insituform Technologies, LLC (Insituform), formerly Insituform Technologies, Inc., a subsidiary of Aegion Corporation, is a provider of cured-in place pipe (CIPP), proprietary technologies and services for the rehabilitation and

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Aug 2017
No. of Pages :17
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube